Antineuronal antibodies in a heterogeneous group of youth and young adults with tics and obsessive-compulsive disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 25, Issue 1, 2015, Pages 76-85

  Cox, Carol J ^a   Zuccolo, Amir J ^a   Edwards, Erica V ^a   Mascaro Blanco, Adita ^a   Alvarez, Kathy ^a   Stoner, Julie ^b   Chang, Kiki ^c   Cunningham, Madeleine W ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CELL ANTIBODY; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; NEURONAL ANTIBODY; TUBULIN; UNCLASSIFIED DRUG; AUTOANTIBODY;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CAUCASIAN; CHILD; CHOREA MINOR; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUP A STREPTOCOCCAL INFECTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL DISEASE; NERVE CELL; OBSESSIVE COMPULSIVE DISORDER; PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCI; STREPTOCOCCUS INFECTION; THROAT CULTURE; TIC; BLOOD; COMPLICATION; OBSESSIVE-COMPULSIVE DISORDER; PRESCHOOL CHILD; STREPTOCOCCAL INFECTIONS; TICS; TUMOR CELL LINE; YOUNG ADULT;

ADOLESCENT; ADULT; AUTOANTIBODIES; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; MALE; NEURONS; OBSESSIVE-COMPULSIVE DISORDER; STREPTOCOCCAL INFECTIONS; TICS; YOUNG ADULT;

EID: 84923293948     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2014.0048     Document Type: Article

References (47)

1. Allen AJ, Leonard HL, Swedo SE: Case-Study-A new infectiontriggered, autoimmune subtype of pediatric OCD and Tourettessyndrome. J Am Acad Child Adolesc Psychiatry 34:307-311, 1995.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
3. Bejar R, Yasuda R, Krugers H, Hood K, Mayford M: Transgenic calmodulin-dependent protein kinase II activation: Dose-dependent effects on synaptic plasticity, learning, and memory. J Neurosci 22:5719-5726, 2002.
4. Ben-Pazi H, Stoner JA, Cunningham MW: Dopamine receptor autoantibodies correlate with symptoms in Sydenham's Chorea. PLoS One 8:1-6, 2013.
5. Black JL, Lamke GT, Walikonis JE: Serologic survey of adult patients with obsessive-compulsive disorder for neuron-specific and other autoantibodies. Psychiatry Res 81:371-380, 1998.
6. Brilot F, Merheb V, Ding A, Murphy T, Dale RC: Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 76:1508-1513, 2011.
7. Brimberg L, Benhar I, Mascaro-Blanco A, Alvarez K, Lotan D, Winter C, Klein J, Moses AE, Somnier FE, Leckman JF, Swedo SE, Cunningham MW, Joel D: Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: A novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 37:2076-2087, 2012.
8. Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G: Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology 59:227-231, 2002.
9. Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM: Tourette's syndrome: A cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 74:602-607, 2003.
10. Cox CJ, Sharma M, Leckman JF, Zuccolo J, Zuccolo A, Kovoor A, Swedo SE, Cunningham MW: Brain human monoclonal autoantibody from Sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: Implications in human disease. J Immunol 191:5524-5541, 2013.
11. Dale RC, Candler PM, Church AJ, Wait R, Pocock JM, Giovannoni G: Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol 172:187-197, 2006.
12. Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, Ben-Pazi H, Varadkar S, Aumann TD, Horne MK, Church AJ, Fath T, Brilot F: Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 135:3453-3468, 2012.
13. De Koninck P, Schulman H: Sensitivity of CaM kinase II to the frequency of Ca2 + oscillations. Science 279:227-230, 1998.
14. Hoffman KL, Hornig M, Yaddanapudi K, Jabado O, Lipkin WI: A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. J Neurosci 24:1780-1791, 2004.
15. Husby G, van de Rijn I, Zabriskie JB, Abdin ZH, Williams RC: Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 144:1094-1110, 1976.
16. Kaplan EL, Rothermel CD, Johnson DR: Antistreptolysin O and antideoxyribonuclease B titers: Normal values for children ages 2 to 12 in the United States. Pediatrics 101:86-88, 1998.
17. Kiessling LS, Marcotte AC, Culpepper L: Anti-neuronal antibodies in movement disorders. Pediatrics 92:39-43, 1993.
18. Kiessling LS, Marcotte AC, Culpepper L: Antineuronal antibodies-Tics and obsessive-compulsive symptoms. J Dev Behav Pediatr 15:421-425, 1994.
19. Kirvan CA, Cox CJ, Swedo SE, Cunningham MW: Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. Journal of Immunology 178(11):7412-7421, 2007.
20. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW: Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9:914-920, 2003.
21. Kirvan CA, Swedo SE, Kurahara D, Cunningham MW: Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity 39:21-29, 2006a.
22. Kirvan CA, Swedo SE, Snider LA, Cunningham MW: Antibodymediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 179:173-179, 2006b.
23. Kondo K, Kabasawa T: Improvement in Gilles de La Tourette Syndrome after corticosteroid-therapy. Ann Neurol 4:387, 1978.
24. Kurlan R, Johnson D, Kaplan EL, Tourette Syndrome Study Group: Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: A prospective blinded cohort study. Pediatrics 121:1188-1197, 2008.
25. Leckman JF, King RA, Gilbert DL, Coffey BJ, Singer HS, Dure LS, Grantz H, Katsovich L, Lin H, Lombroso PJ, Kawikova I, Johnson DR, Kurlan RM, Kaplan EL: Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: A prospective longitudinal study. J Am Acad Child Adolesc Psychiatry 50:108-118, 2011.
26. Luo F, Leckman JF, Katsovich L, Findley D, Grantz H, Tucker DM, Lombroso PJ, King RA, Bessen DE: Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: Relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 113:e587-585, 2004.
27. Marques-Dias MJ, Mercadante MT, Tucker D, Lombroso P: Sydenham's chorea. Psychiatr Clin North Am 20:809-820, 1997.
28. Martino D, Chiarotti F, Buttiglione M, Cardona F, Creti R, Nardocci N, Orefici G, Veneselli E, Rizzo R, Gr ITSS: The relationship between group A streptococcal infections and Tourette syndrome: A study on a large service-based cohort. Dev Med Child Neurol 53:951-957, 2011.
29. Matarazzo E: Tourette's syndrome treated with ACTH and prednisone: Teport of two cases. J. Child Adolesc Psychopharmacol 2:215-226, 1992.
30. Menegon A, Verderio C, Leoni C, Benfenati F, Czernik AJ, Greengard P, Matteoli M, Valtorta F: Spatial and temporal regulation of Ca2 + /calmodulin-dependent protein kinase II activity in developing neurons. J Neurosci 22:7016-7026, 2002.
31. Mohammad SS, Ramanathan S, Brilot F, Dale RC: Autoantibodyassociated movement disorders. Neuropediatrics 44:336-345, 2013.
32. Morris CM, Pardo-Villamizar C, Gause CD, Singer HS: Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci 276:45-48, 2009.
33. Murphy M, Pichichero ME: Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 156:356-361, 2002.
34. Murphy TK, Sajid M, Soto O, Shapira N, Edge P, Yang M, Lewis MH, Goodman WK: Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessivecompulsive disorder and tics. Biol Psychiatry 55:61-68, 2004.
35. Murphy TK, Snider LA, Mutch PJ, Harden E, Zaytoun A, Edge PJ, Storch EA, Yang MC, Mann G, Goodman WK, Swedo SE: Relationship of movements and behaviors to Group A Streptococcus infections in elementary school children. Biol Psychiatry 61:279-284, 2007.
36. Murphy TK, Storch EA, Lewin AB, Edge PJ, Goodman W: Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr 160:314-319, 2012.
37. Pathmanandavel K, Starling J, Dale RC, Brilot F: Autoantibodies and the immune hypothesis in psychotic brain diseases: Challenges and perspectives. Clin Dev Immunol 2013:257184, 2013.
38. Pavone P, Parano E, Rizzo R, Trifiletti RR: Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants. J Child Neurol 21:727-736, 2006.
39. Perlmutter SJ, Leitman SF, Garvey MA, Hamburger S, Feldman E, Leonard HL, Swedo SE: Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354:1153-1158, 1999.
40. Ramanathan S, Mohammad SS, Brilot F, Dale RC: Autoimmune encephalitis: Recent updates and emerging challenges. J Clin Neurosci 21:722-730, 2013.
41. Singer HS, Giuliano JD, Hansen BH, Hallett JJ, Laurino JP, Benson M, Kiessling LS: Antibodies aginst human putamen in children with Tourette syndrome. Neurology 50:1618-1624, 1998.
42. Singer HS, Hong JJ, Yoon DY, Williams PN: Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 65:1701-1707, 2005.
43. Swedo SE: Sydenham's chorea: A model for childhood autoimmune neuropsychiatric disorders. JAMA 272:1788-1791, 1994.
44. Swedo SE, Leckman JF, Rose NR: From research subgroup to clinical syndrome: Modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome). Pediatr Ther 2:1-8, 2012.
45. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Lougee L, Dow S, Zamkoff J, Dubbert BK: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry 155:264-271, 1998.
46. Tsui J, Inagaki M, Schulman H: Calcium/calmodulin-dependent protein kinase II ( CaMKII) localization acts in concert with substrate targeting to create spatial restriction for phosphorylation. J Biol Chem 280:9210-9216, 2005.
47. Yaddanapudi K, Hornig M, Serge R, De Miranda J, Baghban A, Villar G, Lipkin WI: Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol Psychiatry 15:712-726, 2010.